Akron Children's > For Families & Patients > Research > Pediatric Clinical Studies > Open Clinical Studies

Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Newly Diagnosed Non-Rhabdomyosarcoma Soft Tissue Sarcomas (ARST1321)

Radiation Therapy Before Surgery in patients Non-Rhabdomyosarcoma Soft Tissue Sarcomas

Description:

For complete study information, please view the study on clinicaltrials.gov.

Study Status:

Closed

Full IRB Study Title:

ARST1321: Pazopanib Neoadjuvant Trial in Non-rhabdomyosarcoma Soft Tissue Sarcomas (PAZNTIS): A Phase II/III Randomized Trial of Preoperative Chemoradiation or Preoperative Radiation Plus or Minus Pazopanib (NSC# 737754)

IRB Study ID:

150204

If you are interested in this study or have questions about your child's eligibility, please contact:

Rebecca D. Considine Research Institute, 330-543-3193 or email research@akronchildrens.org

Lead Investigator

Steven Kuerbitz, MD

Director, Divisional Research, Shannon E. Wilkes Targeted Therapy Program; The Jeffrey A. Barbour Chair for Pediatric Hematology/Oncology Research and Healing; Pediatric Hematologist-Oncologist
Showers Family Center for Childhood Cancer and Blood DisordersPediatric Stem Cell Transplant Program

Search our Site

Need Help?

Operator

Ask Children's

For Family & Patients

Go to section...

Quicklinks

Find-A-Provider

Find-A-Location

Services

Health Info

About Us

Research

Your Visit

Search our site:

Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Newly Diagnosed Non-Rhabdomyosarcoma Soft Tissue Sarcomas (ARST1321)

Radiation Therapy Before Surgery in patients Non-Rhabdomyosarcoma Soft Tissue Sarcomas

Starting Locations:

Legal:

Mobile App:

About Akron Children's